Information
for investors

hero background image

Financial
information

arrow-down

Some of the information or materials made available on this website may contain forward-looking statements. Statements including words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to assumptions, risks and uncertainties that could cause actual events or actual future results to differ materially from the expectations set forth in the forward-looking statements.

SEC Filings

arrow-down
arrow-down
Date Filling type Description
Nov 12, 2024 F-3 Registration statement by foreign private issuers arrow
Oct 30, 2024 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] arrow
Oct 16, 2024 6-k Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
Oct 7, 2024 6-k Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
Sep 20, 2024 S-8 Securities to be offered to employees in employee benefit plansOpen document arrow
Sep 13, 2024 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
Aug 9, 2024 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
Jul 15, 2024 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
Jul 2, 2024 424B3 Prospectus [Rule 424(b)(3)] arrow
Jul 2, 2024 424B3 Prospectus [Rule 424(b)(3)] arrow
Jun 28, 2024 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
May 31, 2024 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
May 24, 2024 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
Apr 30, 2024 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
Apr 30, 2024 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
Apr 29, 2024 424B3 Prospectus [Rule 424(b)(3)] arrow
Apr 29, 2024 424B3 Prospectus [Rule 424(b)(3)] arrow
Apr 23, 2024 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
Apr 18, 2024 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
Apr 17, 2024 SC 13D General statement of acquisition of beneficial ownership arrow
Apr 10, 2024 SC 13D/A General statement of acquisition of beneficial ownership - amendment arrow
Mar 12, 2024 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
Feb 26, 2024 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
Feb 15, 2024 424B3 Prospectus [Rule 424(b)(3)] arrow
Feb 15, 2024 424B3 Prospectus [Rule 424(b)(3)] arrow
Jan 22, 2024 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
Nov 16, 2023 424B3 Prospectus [Rule 424(b)(3)] arrow
Nov 16, 2023 424B3 Prospectus [Rule 424(b)(3)] arrow
Nov 16, 2023 EFFECT Notice of Effectiveness arrow
Nov 16, 2023 EFFECT Notice of Effectiveness arrow
Nov 15, 2023 POS AM Post-Effective amendments for registration statement arrow
Nov 13, 2023 POS AM Post-Effective amendments for registration statement arrow
Nov 2, 2023 20-F/A Annual and transition report of foreign private issuers [Sections 13 or 15(d)] - amendment arrow
Oct 30, 2023 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] arrow
Oct 18, 2023 6-K Press Release Business Update arrow
Oct 17, 2023 6-K Press Release Capital Raise with Strategic Investors arrow
Jul 18, 2023 424B3 Prospectus [Rule 424(b)(3)] arrow
Jul 10, 2023 424B3 Prospectus [Rule 424(b)(3)] arrow
Jul 10, 2023 424B3 Prospectus [Rule 424(b)(3)] arrow
Jul 10, 2023 6-K Financial Statements arrow
Jun 26, 2023 6-K Piggy Sooy Press Release arrow
Jun 7, 2023 424B3 Prospectus [Rule 424(b)(3)] arrow
Jun 1, 2023 6-K 3Q23 Business Update Press Release arrow
May 10, 2023 424B3 Prospectus [Rule 424(b)(3)] arrow
Apr 17, 2023 6-K Equity Subscription Line arrow
Apr 17, 2023 F-1 Registration statement for certain foreign private issuers arrow
Apr 11, 2023 6-K Moolec Science Acquires Food Ingredient Capabilities to Consolidate Molecular Farming Technology arrow
Apr 5, 2023 6-K Moolec Science Achieves USDA-APHIS Regulatory Status Review Clearance for Molecular Farming Product arrow
Apr 4, 2023 424B3 Prospectus [Rule 424(b)(3)] arrow
Apr 3, 2023 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] arrow
Mar 31, 2023 POS AM Post-Effective amendments for registration statement arrow
Mar 27, 2023 EFFECT Notice of Effectiveness arrow
Mar 27, 2023 424B3 Prospectus [Rule 424(b)(3)] arrow
Mar 22, 2023 F-1/A Registration statement for certain foreign private issuers - amendment arrow
Mar 17, 2023 F-1/A Registration statement for certain foreign private issuers - amendment arrow
Jan 31, 2023 DEL AM Delaying amendment arrow
Jan 27, 2023 F-1 Registration statement for certain foreign private issuers arrow
Jan 9, 2023 SC 13D General statement of acquisition of beneficial ownership arrow
Jan 9, 2023 SC 13D General statement of acquisition of beneficial ownership arrow
Jan 6, 2023 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d) arrow
Jan 3, 2023 6-K Press Release for Closing of Business Combination arrow
Dec 30, 2022 Form - CERT Nasdaq's certification of the registrant's application on Form 8-A 12(b) arrow
Dec 30, 2022 8-A12B Registration of securities [Section 12(b)] arrow
Dec 5, 2022 EFFECT Notice of Effectiveness arrow
Dec 5, 2022 424B3 Prospectus arrow
Dec 2, 2022 425 Investor Presentation Filing arrow
Dec 1, 2022 F-4/A Registration of securities, foreign private issuers, business combinations-amendment arrow
Nov 21, 2022 F-4/A Registration of securities, foreign private issuers, business combinations-amendment arrow
Oct 28, 2022 425 Investor Presentation Filing arrow
Oct 18, 2022 425 Prospectuses and communications, business combinations arrow
Oct 17, 2022 F-4 Registration of securities, foreign private issuers, business combinations arrow
Sep 27, 2022 DRS/A Draft Registration Statement - amendment arrow
Aug 12, 2022 DRS Draft Registration Statement arrow
Jun 14, 2022 8-K Business Combination Agreement arrow

Analyst Coverage

Company Analyst
Roth Capital
Maxim Group Anthony Vendetti

Let's redefine the way we produce animal proteins
for the good of the planet.

Send us an email [email protected]

Book a meeting with our IR people Download Media Kit